________________________________________________________________________REFERENCIAS
57
ABBAS, A. K.; LICHTMAN, A. H. Imunidade contra tumors. In:_________________.
Imunologia celular e molecular. Rio de Janeiro: Elsevier. Cap. 17, p. 401-421, 2005
ARAGÃO, A. J. O exame físico na avaliação do câncer de próstata. In:
WROCLAWSKI, E. R.; BENDHACK, D. A.; DAMIÃO, R.; ORTIZ, V. Guia Prático
de Urologia. São Paulo: Segmento. cap. 130, p. 437-438, 2003.
ARAP, W.; KOLONIN, M. G.; TREPEL, M.; LAHDENRANTA, J.; CARDO-VILA,
M.; GIORDANO, R. J.; MINTZ, P. J.; ARDELT, P. U.; YAO, V. J.; VIDAL, C. I.;
CHEN, L.; FLAMM, A.; VALTANEN, H.; WEAVIND, L. M.; HICKS, M. E.;
POLLOCK, R. E.; BOTZ, G. H.; BUCANA, C. D.; KOIVUNEN, E.; CAHILL, D.;
TRONCOSO, P.; BAGGERLY, K. A.; PENTZ, R. D.; DO, K. A.; LOGOTHETIS, C.
J.; PASQUALINI, R. Steps toward mapping the human vasculature by phage display.
Nat Med. New York. v. 8 n. 2 p. 121-127. Fev. 2002.
AVRAMIS, V. I.; AVRAMIS, E. V.; HUNTER, W.; LONG, M. C. Immunogenicity of
Native or Pegylated E. coli and Erwinia Asparaginases Assessed by ELISA and Surface
Plasmon Resonance (SPR-Biacore) Assays of IgG Antibodies (Ab) in Sera from
Patients with Acute Lymphoblastic Leukemia (ALL). Anticancer Research. Attiki. v.
29. n. 1. p. 299-302. Jan. 2009.
AZZAY, H. M. E.; HIGHSMITH, W. E. Phage display technology: clinical
applications and recent inNovations. Clin Biochem, Canada. v.35. n. 6. p.425-445, Set.
2002.
BANEZ, L. L.; P. PRASANNA, L. SUN, A. ALI, Z. ZOU, B.L. ADAM, D.G.
MCLEOD, J.W. MOUL, S. SRIVASTAVA. Diagnostic potential of serum proteomic
patterns in prostate cancer. Journal of Urology. Hagerstown. v. 170. n. p. 442-446.
Ago. 2003.
BARBAS, C.F.III, BURTON, D.R., SCOTT, J.K., SILVERMAN, G.J. Phage Display:
A Laboratory Manual. Plain View, NY: Cold Spring Harbor Laboratory Press, 2001.
BAZHIN, A. V.; SAVCHENKO, M. S.; SHIFRIN, O. N.; DEMOURA, S.A.;
CHIKINA, S. Y.; JAQUES, G.; KOGAN, E. A.; CHUCHALIN, A. G.; PHILIPPOV,